Fujisawa, Japan

Takehiro Okada


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takehiro Okada: Innovator in Pharmaceutical Chemistry

Introduction

Takehiro Okada is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents to his name, Okada's work has the potential to impact the development of new medications.

Latest Patents

One of Okada's latest patents is focused on Aerothricin derivatives. This invention relates to novel Aerothricins represented by the Formula (I) and pharmaceutically acceptable salts thereof. The patent also includes a pharmaceutical composition comprising an Aerothricin of the Formula (I) and a pharmaceutically acceptable carrier. Furthermore, it discusses the use of such Aerothricins for the preparation of medicaments, as well as processes for their preparation. Another significant patent involves Dolastatin 10 derivatives, showcasing his expertise in creating valuable pharmaceutical compounds.

Career Highlights

Throughout his career, Takehiro Okada has worked with prominent companies in the pharmaceutical industry. Notable among these are Basilea Pharmaceutica AG and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his development as an inventor and researcher.

Collaborations

Okada has collaborated with esteemed colleagues, including Masami Kohchi and Kazunao Masubuchi. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Takehiro Okada's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…